Although BL cases usually present a well-defined cytogenetic abnormality, in the translocation of the MYC gene, they are also much more complex and heterogenous than ALL tumors, thus being under the influence of diverse oncogenic pathways that may have redundant effects in maintaining cell survival [55]. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.